2016
DOI: 10.1016/j.lungcan.2016.02.004
|View full text |Cite
|
Sign up to set email alerts
|

A sensitive and high throughput TaqMan-based reverse transcription quantitative polymerase chain reaction assay efficiently discriminates ALK rearrangement from overexpression for lung cancer FFPE specimens

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
4
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 35 publications
0
4
0
Order By: Relevance
“…It is important to note that IHC, like the RT-PCR assay used in this report, is not capable of differentiating ALK fusion-positive versus full-length ALK-positive NSCLC; thus, occasional cases of IHC-positive lung cancer could possibly express full-length ALK rather than the chimeric kinase although none of our 4 cases were IHC-positive. RT-PCR assays that assess the balance between expression of 5′ ALK (representing transcripts indicative of the full-length receptor tyrosine kinase) relative to 3′ ALK transcripts (that are common to both full-length and fusion forms of ALK ) have been designed for this discrimination [ 14 , 24 ]; however, the ALK RGQ RT-PCR Kit targets only the 3′ region of the ALK transcript which encodes the kinase domain. Amplification or increased copy number of full-length ALK has been reported in NSCLC tumors [ 25 ], but is not thought to be an oncogenic driver.…”
Section: Discussionmentioning
confidence: 99%
“…It is important to note that IHC, like the RT-PCR assay used in this report, is not capable of differentiating ALK fusion-positive versus full-length ALK-positive NSCLC; thus, occasional cases of IHC-positive lung cancer could possibly express full-length ALK rather than the chimeric kinase although none of our 4 cases were IHC-positive. RT-PCR assays that assess the balance between expression of 5′ ALK (representing transcripts indicative of the full-length receptor tyrosine kinase) relative to 3′ ALK transcripts (that are common to both full-length and fusion forms of ALK ) have been designed for this discrimination [ 14 , 24 ]; however, the ALK RGQ RT-PCR Kit targets only the 3′ region of the ALK transcript which encodes the kinase domain. Amplification or increased copy number of full-length ALK has been reported in NSCLC tumors [ 25 ], but is not thought to be an oncogenic driver.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, various IHC platforms have differing sensitivity and specificity (Table 1) [29]. It has been proposed IHC and FISH complement one another and that combined testing may enhance the detection of ALK-positive cases [30, 31]. …”
Section: Methods Of Testingmentioning
confidence: 99%
“…After A-tailing, adaptor ligation, single primer extension, and streptavidin capture enrichment, 3 kb and 4.5 kb bands for LC-2/ad cells and H3122 cells were efficiently and successfully amplified in the first PCR reaction, respectively. The performance and reliability of the ligation-mediated PCR method for the identification of the chromosomal breakpoint of a fusion gene in clinical samples were also demonstrated using an ALK fusion gene-positive lung cancer sample identified in our earlier work [ 11 ] and a 5.1 kb amplicon was recovered ( Fig. 2 ).…”
Section: Resultsmentioning
confidence: 61%